We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Clinical Updates

Enhancing Prognosis in FSGS and MCD through Computational Tubular Feature Analysis

MedXY Editorial Team•Oct 2, 2025•Clinical Updates
Computational PathologyFSGS

Highlight

– Computational analysis of tubular features from whole slide images offers enhanced prognostic discrimination in FSGS and MCD compared to conventional assessments.
– Nine specific tubular features, including basement membrane thickness and epithelial flattening, correlate strongly with disease progression and proteinuria remission.
– Tubular morphology changes show a gradient with interstitial fibrosis severity, highlighting spatial relationships important for understanding pathophysiology.
– Integration of deep learning and pathomics enables quantitative, reproducible insights into tubular pathology beyond traditional visual scoring.

Study Background and Disease Burden

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Beyond Simple Quantification: How AI and Tumor-Stroma Ratio Are Redefining Prognosis Prediction in Hepatocellular CarcinomaResearchers have developed an AI-powered framework that uncovers a non-linear relationship between tumor-stroma ratio and mortality in hepatocellular carcinoma, using a novel token-guided multimodal fusion approach to improve prognostic accApr 9, 2026Selective TRPC6 Inhibition Emerges as a Novel Therapeutic Paradigm for Focal Segmental GlomerulosclerosisA Phase 2 trial of BI 764198, a selective TRPC6 inhibitor, demonstrates significant proteinuria reduction in patients with focal segmental glomerulosclerosis. This study provides the first clinical evidence for podocyte-targeted therapy, maFeb 15, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story